Please login to the form below

Not currently logged in
Email:
Password:

New accounts: May

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February to April 2005 inclusive.
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February to April 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, e-mail nhobson@pmlive.com

AstraZeneca

Faslodex

Breast cancer

The Medical Multimedia Company

Genzyme

Thyrogen

Oncology

Big Blue

Genzyme Therapeutics

Corporate

Corporate

Langland

GlaxoSmithKline

New product

Neurology

Euro RSCG Life MSC

Intervet

Ibaflin gel

Antibiotic

Woolley Pau

Lilly

Corporate

Diabetes

PAN Advertising

Lilly

Humalog insulins and devices

Diabetes

PAN Advertising

Novartis

Zelnorm

IBS

The Medical Multimedia Company

Novo Nordisk

Diabetes insulin portfolio

Diabetes

Woolley Pau

Orion Pharma

Tridestra

HRT

Langland

Orion Pharma

Indivina

HRT

Langland

Roche

Avastin

Colorectal cancer

MJL Advertising

sanofi-aventis

Taxotere

Oncology

Medicus London

sanofi-aventis

Arava

Arthritis

Medicus London

sanofi-aventis

Targocid

Anti-infective

Medicus London

sanofi-aventis

Xatral

Benign prostatic hyperplasia

Medicus London

sanofi-aventis

Tavanic

Anti-infective

Medicus London

Schering-Plough

Subutex

Opioid dependence

Medicus London

Schering-Plough

Viraferon-Peg

Hepatitis C

Medicus London

Vernacare

Portfolio

Infection control

Mason Zimbler

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics